Theramab

Develop immunotherapeutic monoclonal antibodies (MAbs) for treating diseases in the field of autoimmunity and cancer

placeMoscow, Moscow, Russia calendar_todayFounded 2009 groups4 employees language theramab.ru

Innovation

14 patent families (11 granted) — focus: Chemistry & metallurgy, Physics & computing, Human necessities; filing pace dormant. Cited 269 times.

YearFilings
20128
20134
20142
20156
20162
20171

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%
Coming soon